Clinical Trial

Evaluation of Safety and Efficacy of Nalbuphine Versus Morphine for Postoperative Analgesia

Name: Evaluation of Safety and Efficacy of Nalbuphine Versus Morphine for Postoperative Analgesia — clinical trial record (NCT06949852)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

Evaluation of safety and efficacy of Nalbuphine versus Morphine patient controlled intravenous analgesia (PCIA) for the treatment of postoperative analgesia

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-04-21.

Status change: Recruiting → Completed 2026-06-24

Trial Details

NCT Number	NCT06949852
Lead Sponsor	Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
Conditions	Postoperative Analgesia
Enrollment	289 participants
Start Date	2024-08-07
Primary Completion	2025-07-08 (estimated)
Study Completion	2025-08-04 (estimated)
Updated on ClinicalTrials.gov	2026-06-25